Class of Antiretroviral Drugs and the Risk of Myocardial Infarction.
Lundgren, J. D.; Weber, R.; Monforte, A. D'Arminio; El-Sadr, W. M.; Reiss, P.; Dabis, F.; Morfeldt, L.; De Wit, S.; Pradier, C.; Calvo, G.; Law, M.; Kirk, O.; Phillips, A. N.; Collins, S.; Loeliger, E.; Tressler, R.; Weller, I.; Friis-Müller, N.; Worm, S. W.; Sabin, C. A.; New England Journal of Medicine, 2007, vol. 356, issue 17, p 1723, ISSN 00284793. ISBN 00284793.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef